Epstein Secrets

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

rity." Meanwhile, the Washington Times <https://wvvw.washingtontimes.com/news/2020/oct/8/elissa-slotkin-former- cia-analyst-accuses-dni-johnk (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Inte

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,

tant DNI for Strategic Communications Amanda Shoch said Ratcliffe's "top priority is our nation's security." Meanwhile, the Washington Times (10/8, Blake, 492K) reports Rep. Elissa Slotkin (D-MI), who before being elected to Congress served in the CIA and in the Office of the Director of National Int

said Regeneron's early trials data "found patients given the antibody cocktail cleared the virus faster with reduced symptoms. But critics like Dr. Rick Bright fear the emergency approval process is being politicized." Former Biomedical Advanced Research and Development Authority Director Rick Bright said,